NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Fangyuan Capital (Hong Kong) Limited

Fangyuan Capital (Hong Kong) Limited

Hong Kongprudenceinv.com

Overview

Fangyuan Capital (Hong Kong) Limited is a private equity investment firm focused on the life sciences and healthcare sectors.

Year Founded

2017

Portfolio Companies

4

Investments

Fangyuan Capital (Hong Kong) Limited investments
CompanyDateStageLead
InnornaMar 2022Series BCo-investor
苏州易慕峰生物科技有限公司Jan 2022Series ACo-investor
HebeCellAug 2021Series ACo-investor
Just Medical Devices (Tianjin) Co., Ltd.May 2021Series BCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersHong Kong
Year Founded2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.